Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-005785
Filing Date
2019-03-04
Accepted
2019-03-04 16:49:54
Documents
2
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3948
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3762
  Complete submission text file 0000899243-19-005785.txt   9222
Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
McIntyre Gail Frances (Reporting) CIK: 0001492646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 19654563

Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations